![Mark Fishman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Fishman
Directeur/Membre du Conseil chez
BEAM THERAPEUTICS INC.
Fortune : 560 041 $ au 31/05/2026
Profil
Mark C.
Fishman currently works at Beam Therapeutics, Inc., as Lead Independent Director from 2018, Aditum Bio Fund 1 LP, as Director, Versanis Bio, Inc., as Non-Executive Director, Teres Bio, Inc., as Director, Anteris Bio, Inc., as Director, The General Hospital Corp., as Chief-Pathways Clinical Service, and The Children's Hospital of Philadelphia, as Trustee-Emeritus.
Dr. Fishman also formerly worked at Novartis Institute for Functional Genomics, Inc., as Chairman, Semma Therapeutics, Inc., as Chairman from 2016 to 2019, Novartis International Pharmaceutical Ltd., as Director, Cardiovascular Research Center, as Founding Director, Geneception, Inc., as Director, Novartis AG, as Member-Executive Board, Novartis Institutes for Biomedical Research, Inc., as Founding President from 2002 to 2016, The Marine Biological Laboratory, as Trustee, and Harvard Medical School, as Professor.
Dr. Fishman received his undergraduate degree in 1972 from Yale University and doctorate degree in 1976 from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC. 0,02 % | 03/06/2026 | 17 007 ( 0,02 % ) | 560 041 $ | 31/05/2026 |
Postes actifs de Mark Fishman
| Sociétés | Poste | Début |
|---|---|---|
| BEAM THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/05/2018 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Directeur/Membre du Conseil | - |
Anteris Bio, Inc.
 Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Directeur/Membre du Conseil | - |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Aditum Bio Fund 1 LP
 Aditum Bio Fund 1 LP Investment ManagersFinance Functions as a venture capital fund | Directeur/Membre du Conseil | 01/02/2019 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | - |
Teres Bio, Inc.
 Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage life sciences company which develops novel therapies for skin diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Mark Fishman
| Sociétés | Poste | Fin |
|---|---|---|
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Président | 01/01/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/03/2016 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Mark Fishman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
89
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
The Marine Biological Laboratory
 The Marine Biological Laboratory Miscellaneous Commercial ServicesCommercial Services Provides research and educational services | Commercial Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis International Pharmaceutical Ltd.
 Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Cardiovascular Research Center
 Cardiovascular Research Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Aditum Bio Fund 1 LP
Aditum Bio Fund 1 LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Geneception, Inc.
 Geneception, Inc. BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage life sciences company which develops novel therapies for skin diseases | Health Technology |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of renal disease | Health Technology |
